SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-015255
Filing Date
2016-05-02
Accepted
2016-05-02 14:13:38
Documents
69
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pcrx-3312016x10xq.htm 10-Q 826304
2 EXHIBIT 10.1 pcrx-33116xex101.htm EX-10.1 62232
3 EXHIBIT 10.2 pcrx-33116xex102.htm EX-10.2 62200
4 EXHIBIT 31.1 pcrx-33116xex311.htm EX-31.1 14786
5 EXHIBIT 31.2 pcrx-33116xex312.htm EX-31.2 14787
6 EXHIBIT 32.1 pcrx-33116xex321.htm EX-32.1 5627
7 EXHIBIT 32.2 pcrx-33116xex322.htm EX-32.2 5529
  Complete submission text file 0001628280-16-015255.txt   4905146

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pcrx-20160331.xml EX-101.INS 964893
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20160331.xsd EX-101.SCH 36731
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20160331_cal.xml EX-101.CAL 65037
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20160331_def.xml EX-101.DEF 165486
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20160331_lab.xml EX-101.LAB 538670
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20160331_pre.xml EX-101.PRE 298112
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 161611145
SIC: 2834 Pharmaceutical Preparations